Healthtech Startups

Omni AI is an AI-powered practice management and revenue cycle management platform for specialty physician practices, using AI agents to automate front-end administrative work such as benefit verification and prior authorization. It integrates with a practice's EMR, practice management, and clearinghouse systems, including custom connections to local HMO plans, to reduce claim denials and improve collections.

1 investor

OmniActive develops scientifically validated, nature-based ingredients for the nutraceutical and natural products industry. The company specializes in extracting and delivering innovative ingredient solutions sourced from spices and natural materials.

1 investor

OmniBio develops biologically-inspired AI models for autonomous robots and machines used in manufacturing, agriculture, and construction. The technology enables robots to learn and adapt in dynamic environments without traditional sensors or connectivity.

1 investor

OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.

1 investor

Omnicare is a German healthcare group focused on oncology, operating medical care centers (MVZ) with physicians and oncologists across multiple sites, clean-room laboratories, pharmaceutical wholesale, hygiene monitoring, and quality initiatives for pharmacies and oncology practices. It also runs psychosomatic clinics and provides software (eApo) and training for medical staff.

1 investor

OmniCyte is a biotechnology company developing vaccines and cancer immunotherapies, including a SARS-CoV-2 vaccine program and immune-response engineering work conducted in collaboration with academic medical centers. Its research focuses on recombinant vaccine development and immuno-oncology approaches.

1 investor

Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.

1 investor

Omniscience.bio builds Vivo, an agentic AI "control tower" that unifies data from clinical trial systems (EDC, CTMS, labs, safety, imaging, eCOA, IRT, documents) into a governed layer where teams ask plain-language questions, monitor risk, and take source-backed action. It serves cross-functional clinical development teams, sponsors, and CRO/FSP partners running active trials, in the clinical trial software and life sciences category.

1 investor

OmniTier develops on-premise genomics analysis software and systems that use efficient memory-leveraged computing to enable faster and more cost-effective multiomic data analysis compared to cloud-based approaches.

1 investor

Omnivers is a clinical care platform that consolidates patient data and tools—including task management, billing dashboards, telehealth, and remote patient monitoring—into a single interface for healthcare facilities. It integrates with systems such as PointClickCare, Matrix, and Sigma to help caregivers manage visits, documentation, and revenue.

1 investor

Order-made Medical Research Inc. (OMR) develops antibody drug discovery technologies, including its LIMAXYS platform for generating antibodies against multi-pass transmembrane targets, plus the INTAB and MUTAB platforms for internalizing and disease-specific mutation antibodies. The company aims to create new antibody-based therapies for hard-to-treat cancers, autoimmune diseases, and neurodegenerative disorders.

1 investor

OMX is a distribution group for medical technologies and related services that federates companies specialized in specific therapeutic areas, connecting medical device manufacturers with healthcare professionals. Operating in France, it provides member entities with financial resources, shared service infrastructure, and strategic support while helping manufacturers achieve faster market access.

1 investor

ONCALL operates a home medical care support service in Japan, providing night and holiday house-call teams plus an online "Connect" team that supports clinical decisions and links medical institutions and multidisciplinary staff nationwide. It aims to expand young physicians' involvement in home care and improve the quality and supply of home-based medical care, particularly end-of-life care.

1 investor

On the Right Track provides a patented hookless cubicle curtain track system, recyclable and textile curtains, in-person curtain changeout services, and a cloud-based QR-code tracking app for hospitals and healthcare facilities. Its products aim to reduce hospital-associated infections and improve compliance and operational efficiency for regional hospitals, healthcare networks, surgery centers, and similar facilities.

1 investor

Ona provides an AI phone agent for healthcare clinics and practices that answers calls 24/7, books appointments into live calendars, captures patient intake data into charts, and routes complex calls to humans. It serves solo to enterprise medical practices across primary care, behavioral health, physical therapy, and specialty care.

1 investor

Oncare provides cancer treatment with structured, transparent surgery packages, dedicated care coordinators, and end-to-end insurance/cashless paperwork handling. It serves cancer patients in India, drawing on senior oncology specialists trained at institutions such as AIIMS and Tata Memorial Hospital.

1 investor

Oncobox provides low-cost personalized genetic profiling that analyzes tumor DNA, RNA, and molecular pathways to recommend which targeted drugs are likely most effective for an individual late-stage cancer patient. It serves doctors and partners from pharma, hospitals, payers, and genomic centers in oncology.

1 investor

Oncoclínicas operates a network of over 140 units — clinics, genomics and pathology laboratories, and integrated cancer treatment centers — across 40 Brazilian cities. It provides cancer diagnosis and treatment services for patients in Brazil.

1 investor

Oncocross is a South Korean precision medicine company that uses an AI platform built on multi-omics data, with business spanning drug discovery, diagnostics, and clinical applications. It offers LC/MS-based multi-omics analysis, a digital bio-bank of clinical and pathology data, and AI tools for cancer detection and drug indication discovery.

1 investor

OncoForma develops a functional precision oncology platform that tests patient-derived tumor organoids against comprehensive drug panels to predict treatment efficacy before therapy begins. The company serves oncologists and cancer patients in the global oncology market, operating from Saskatchewan with a pathway to scale from fee-for-service testing to AI-enabled predictive medicine.

1 investor

A clinical research organization that conducts clinical trials to provide innovative therapies to patients in specific medical conditions at no additional cost.

1 investor

Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care. It backs companies across value-based oncology, digital health, and cancer treatment models.

1 investor

OncoLux develops an optical theranostic system that gives surgeons intraoperative enhanced visualization of residual cancer and combines it with optical photodynamic therapy to treat remaining tumor tissue during surgery. The technology targets cancer surgery patients and clinicians in the medical device field.

1 investor

OncoNano Medicine develops a proprietary nanotechnology platform for cancer therapeutics that targets the acidic tumor microenvironment to improve drug delivery to tumors. The company serves oncology patients and builds a pipeline of therapies designed for more precise cancer treatment.

1 investor